Guanosine 5-triphosphate,disodium salt hydrate | CAS:56001-37-7

We serve Guanosine 5-triphosphate,disodium salt hydrate CAS:56001-37-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Guanosine 5-triphosphate,disodium salt hydrate

Chemical Name:Guanosine 5‘-triphosphate, disodium salt hydrate
CAS.NO:56001-37-7
Synonyms:Guanosine-5'-triphosphoric aicd disodium salt
Molecular Formula:C10H14N5Na2O14P3
Molecular Weight:567.14400
 
Physical and Chemical Properties:
Melting point:180ºC
Boiling point:1028.3ºC
Flash point:575.7ºC
 
Specification:
Appearance:White to off-white powder
Assay(HPLC):≥98.0%
Loss on drying:≤15%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Guanosine-5'-triphosphate disodium salt (CAS# 56001-37-7) is a nucleotide used in the preparation of photoreactive GTP affinity probes, and in inhibitors of eukaryotic initiation factor eIF-4E.



Contact us for information like Guanosine-5-triphosphoric aicd disodium salt chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Guanosine 5-Triphosphate, Disodium Salt Hydrate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Guanosine 5-Triphosphate, Disodium Salt Hydrate Use and application,Guanosine 5-Triphosphate, Disodium Salt Hydrate technical grade,usp/ep/jp grade.


Related News: The purpose of APIs according to the FDA is to cause ‘pharmacological activity or other direct effects in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the human body.5-bromopyridine-3-carbonitrile manufacturer The Wuhan coronavirus has brought back memories of the 2003 outbreak of the severe acute respiratory syndrome, known as SARS, which infected more than 8,000 people and killed 774.3,5-Difluoroanisole supplier With nearly 194 billion US dollars of original research medicines facing the expiration of patents in the past five years, more and more domestic companies are focusing on the corresponding characteristic APIs, and have started research and development and production preparations in advance. The scale of production and export of APIs will continue to expand and grow.(6R,7R)-7-Amino-8-oxo-3-(prop-1-en-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid vendor Oligomannate, which uses extract from marine brown algae as raw material, received a conditional green light to treat mild-to-moderate level AD, the National Medical Products Administration (NMPA) said in a statement on its website late on Saturday.Apple is temporarily closing all of its stores in China because of the coronavirus outbreak.